Last 12 months
Inside the activity.
0 purchase rows · 83 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 9 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 17 |
| Apr 2026 | 0 | 8 |
| May 2026 | 0 | 9 |
| Jun 2026 | 0 | 8 |
| Jul 2026 | 0 | 9 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 8 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 17, 2024 Filed Jun 17, 2024 21:13 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 11,551 | $52.60 | $607,582.60 |
DisclosureSEC source: 0001127602-24-018855 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 427,594 Read SEC document |
| June 11, 2024 Filed Jun 11, 2024 20:22 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 5,422 | $0.00 Strike: $7.96 | $0.00 |
DisclosureSEC source: 0001127602-24-018365 · form4.xml · derivative · entry 4 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,900 Underlying: Common Stock · 5,422 shares Expires 2025-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 11, 2024 Filed Jun 11, 2024 20:22 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 2,366 | $53.03 | $125,468.98 |
DisclosureSEC source: 0001127602-24-018365 · form4.xml · nonDerivative · entry 3 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 135,004 Read SEC document |
| June 11, 2024 Filed Jun 11, 2024 20:22 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 5,422 | $53.05 | $287,637.10 |
DisclosureSEC source: 0001127602-24-018365 · form4.xml · nonDerivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 137,370 Read SEC document |
| June 11, 2024 Filed Jun 11, 2024 20:22 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionCommon Stock | 5,422 | $7.96 | $43,159.12 |
DisclosureSEC source: 0001127602-24-018365 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 142,792 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 10, 2024 Filed Jun 10, 2024 20:15 UTC |
Bhanji MunaDirector
|
SaleCommon Stock | 2,000 | $52.07 | $104,140.00 |
DisclosureSEC source: 0001127602-24-018246 · form4.xml · nonDerivative · entry 1 Bhanji Muna · CIK 0001846905 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,631 Read SEC document |
| June 04, 2024 Filed Jun 7, 2024 20:03 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 22,500 | $48.85 | $1,099,125.00 |
DisclosureSEC source: 0001127602-24-018143 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 439,145 F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 5, 2024. Read SEC document |
| June 03, 2024 Filed Jun 3, 2024 20:33 UTC |
Wong RobertVP, Chief Accounting Officer
|
SaleCommon Stock | 13,011 | $48.88 | $635,977.68 |
DisclosureSEC source: 0001127602-24-017303 · form4.xml · nonDerivative · entry 1 Wong Robert · CIK 0001777562 · VP, Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,653 Read SEC document |
| June 03, 2024 Filed Jun 4, 2024 20:30 UTC |
PARSHALL B LYNNEDirector
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $10.68 | $0.00 |
DisclosureSEC source: 0001127602-24-017694 · form4.xml · derivative · entry 3 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 5,000 shares Expires 2029-05-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2024 Filed Jun 4, 2024 20:30 UTC |
PARSHALL B LYNNEDirector
|
SaleCommon Stock | 5,000 | $48.64 | $243,200.00 |
DisclosureSEC source: 0001127602-24-017694 · form4.xml · nonDerivative · entry 2 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,600 Read SEC document |
| June 03, 2024 Filed Jun 4, 2024 20:30 UTC |
PARSHALL B LYNNEDirector
|
Exercise / conversionCommon Stock | 5,000 | $10.68 | $53,400.00 |
DisclosureSEC source: 0001127602-24-017694 · form4.xml · nonDerivative · entry 1 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 21:23 UTC |
Harrington Robert ArthurDirector
|
SaleCommon Stock | 1,580 | $48.64 | $76,851.20 |
DisclosureSEC source: 0001127602-24-017963 · form4.xml · nonDerivative · entry 1 Harrington Robert Arthur · CIK 0001923988 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,541 Read SEC document |
| May 31, 2024 Filed Jun 3, 2024 21:07 UTC |
Lee SungEVP, Chief Financial Officer
|
GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 53,417 | $0.00 Strike: $48.51 | $0.00 |
DisclosureSEC source: 0001127602-24-017329 · form4.xml · derivative · entry 2 Lee Sung · CIK 0001793200 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,417 Underlying: Common Stock · 53,417 shares Expires 2034-05-30 F2 · kind: Comprised of non-statutory stock options to purchase shares of common stock and vesting as follows: 25% on the 1-year anniversary of the grant date and the remaining 75% vesting in equal monthly installments over the subsequent 36 months from the 1-year anniversary of the grant date, in each case subject to continued employment. Read SEC document |
| May 31, 2024 Filed Jun 3, 2024 21:07 UTC |
Lee SungEVP, Chief Financial Officer
|
GrantCommon Stock | 34,684 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017329 · form4.xml · nonDerivative · entry 1 Lee Sung · CIK 0001793200 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,684 F1 · kind: Comprised of restricted stock units convertible into shares of common stock on a 1-for-1 basis and vesting as follows: 40% on the 1-year anniversary of the grant date, an additional 40% on the 2-year anniversary of the grant date, and the remaining 20% on the 3-year anniversary of the grant date, in each case subject to the grantee's continued employment. Read SEC document |
| May 15, 2024 Filed May 16, 2024 18:06 UTC |
COSTA SANTO JDirector
|
GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 3,636 | $0.00 Strike: $60.50 | $0.00 |
DisclosureSEC source: 0001127602-24-015724 · form4.xml · derivative · entry 2 COSTA SANTO J · CIK 0001013419 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,636 Underlying: Common Stock · 3,636 shares Expires 2034-05-15 Read SEC document |
| May 15, 2024 Filed May 16, 2024 18:06 UTC |
COSTA SANTO JDirector
|
GrantCommon Stock | 5,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-015724 · form4.xml · nonDerivative · entry 1 COSTA SANTO J · CIK 0001013419 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,600 Read SEC document |
| May 15, 2024 Filed May 16, 2024 22:01 UTC |
PARSHALL B LYNNEDirector
|
GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 3,636 | $0.00 Strike: $60.50 | $0.00 |
DisclosureSEC source: 0001127602-24-015720 · form4.xml · derivative · entry 2 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,636 Underlying: Common Stock · 3,636 shares Expires 2034-05-15 Read SEC document |
| May 15, 2024 Filed May 16, 2024 22:01 UTC |
PARSHALL B LYNNEDirector
|
GrantCommon Stock | 5,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-015720 · form4.xml · nonDerivative · entry 1 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,600 Read SEC document |
| May 15, 2024 Filed May 16, 2024 22:17 UTC |
Bhanji MunaDirector
|
GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 3,636 | $0.00 Strike: $60.50 | $0.00 |
DisclosureSEC source: 0001127602-24-015725 · form4.xml · derivative · entry 2 Bhanji Muna · CIK 0001846905 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,636 Underlying: Common Stock · 3,636 shares Expires 2034-05-15 Read SEC document |
| May 15, 2024 Filed May 16, 2024 22:17 UTC |
Bhanji MunaDirector
|
GrantCommon Stock | 5,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-015725 · form4.xml · nonDerivative · entry 1 Bhanji Muna · CIK 0001846905 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,631 Read SEC document |
| May 15, 2024 Filed May 16, 2024 22:05 UTC |
Harrington Robert ArthurDirector
|
GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 3,636 | $0.00 Strike: $60.50 | $0.00 |
DisclosureSEC source: 0001127602-24-015723 · form4.xml · derivative · entry 2 Harrington Robert Arthur · CIK 0001923988 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,636 Underlying: Common Stock · 3,636 shares Expires 2034-05-15 Read SEC document |
| May 15, 2024 Filed May 16, 2024 22:05 UTC |
Harrington Robert ArthurDirector
|
GrantCommon Stock | 5,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-015723 · form4.xml · nonDerivative · entry 1 Harrington Robert Arthur · CIK 0001923988 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,121 Read SEC document |
| May 15, 2024 Filed May 16, 2024 22:04 UTC |
HENDERSON JOHN TDirector
|
GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 3,636 | $0.00 Strike: $60.50 | $0.00 |
DisclosureSEC source: 0001127602-24-015722 · form4.xml · derivative · entry 3 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,636 Underlying: Common Stock · 3,636 shares Expires 2034-05-15 Read SEC document |
| May 15, 2024 Filed May 16, 2024 22:04 UTC |
HENDERSON JOHN TDirector
|
GrantCommon Stock | 5,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-015722 · form4.xml · nonDerivative · entry 1 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,670 Read SEC document |
| May 15, 2024 Filed May 16, 2024 22:03 UTC |
Kaye Edward M. MDDirector
|
GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 3,636 | $0.00 Strike: $60.50 | $0.00 |
DisclosureSEC source: 0001127602-24-015721 · form4.xml · derivative · entry 2 Kaye Edward M. MD · CIK 0001522780 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,636 Underlying: Common Stock · 3,636 shares Expires 2034-05-15 Read SEC document |
| May 15, 2024 Filed May 16, 2024 22:03 UTC |
Kaye Edward M. MDDirector
|
GrantCommon Stock | 5,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-015721 · form4.xml · nonDerivative · entry 1 Kaye Edward M. MD · CIK 0001522780 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,917 Read SEC document |
| May 15, 2024 Filed May 16, 2024 22:00 UTC |
WIERENGA WENDALLDirector
|
GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 3,636 | $0.00 Strike: $60.50 | $0.00 |
DisclosureSEC source: 0001127602-24-015719 · form4.xml · derivative · entry 2 WIERENGA WENDALL · CIK 0001235945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,636 Underlying: Common Stock · 3,636 shares Expires 2034-05-15 Read SEC document |
| May 15, 2024 Filed May 16, 2024 22:00 UTC |
WIERENGA WENDALLDirector
|
GrantCommon Stock | 5,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-015719 · form4.xml · nonDerivative · entry 1 WIERENGA WENDALL · CIK 0001235945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,327 Read SEC document |
| May 15, 2024 Filed May 16, 2024 21:59 UTC |
Wysenski NancyDirector
|
GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 3,636 | $0.00 Strike: $60.50 | $0.00 |
DisclosureSEC source: 0001127602-24-015718 · form4.xml · derivative · entry 2 Wysenski Nancy · CIK 0001294596 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,636 Underlying: Common Stock · 3,636 shares Expires 2034-05-15 Read SEC document |
| May 15, 2024 Filed May 16, 2024 21:59 UTC |
Wysenski NancyDirector
|
GrantCommon Stock | 5,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-015718 · form4.xml · nonDerivative · entry 1 Wysenski Nancy · CIK 0001294596 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,756 Read SEC document |
| May 07, 2024 Filed May 7, 2024 20:37 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionIncentive Stock Option (Right to Buy) · Derivative | 14,186 | $0.00 Strike: $6.67 | $0.00 |
DisclosureSEC source: 0001127602-24-014445 · form4.xml · derivative · entry 4 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,186 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 26, 2023. Read SEC document |
| May 07, 2024 Filed May 7, 2024 20:37 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 1,361 | $65.11 | $88,614.71 |
DisclosureSEC source: 0001127602-24-014445 · form4.xml · nonDerivative · entry 3 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 137,056 F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 26, 2023. Read SEC document |
| May 07, 2024 Filed May 7, 2024 20:37 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 14,186 | $65.11 | $923,650.46 |
DisclosureSEC source: 0001127602-24-014445 · form4.xml · nonDerivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 138,417 F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 26, 2023. Read SEC document |
| May 07, 2024 Filed May 7, 2024 20:37 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionCommon Stock | 14,186 | $6.67 | $94,620.62 |
DisclosureSEC source: 0001127602-24-014445 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 152,603 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 26, 2023. Read SEC document |
| April 25, 2024 Filed Apr 25, 2024 22:54 UTC |
HENDERSON JOHN TDirector
|
SaleCommon Stock | 10,562 | $64.54 | $681,671.48 |
DisclosureSEC source: 0001127602-24-013411 · form4.xml · nonDerivative · entry 1 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,070 F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 18, 2023. Read SEC document |
| April 12, 2024 Filed Apr 15, 2024 20:02 UTC |
Malik Fady IbrahamEVP Research & Development
|
GiftCommon Stock | 150 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-012878 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,417 Read SEC document |
| April 09, 2024 Filed Apr 9, 2024 20:38 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 28,605 | $0.00 Strike: $6.67 | $0.00 |
DisclosureSEC source: 0001127602-24-012715 · form4.xml · derivative · entry 4 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,605 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 09, 2024 Filed Apr 9, 2024 20:38 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 4,000 | $74.32 | $297,280.00 |
DisclosureSEC source: 0001127602-24-012715 · form4.xml · nonDerivative · entry 3 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 138,567 Read SEC document |
| April 09, 2024 Filed Apr 9, 2024 20:38 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 28,605 | $74.31 | $2,125,637.55 |
DisclosureSEC source: 0001127602-24-012715 · form4.xml · nonDerivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 142,567 Read SEC document |
| April 09, 2024 Filed Apr 9, 2024 20:38 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionCommon Stock | 28,605 | $6.67 | $190,795.35 |
DisclosureSEC source: 0001127602-24-012715 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 171,172 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 23:07 UTC |
Wong RobertVP, Chief Accounting Officer
|
GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 3,308 | $0.00 Strike: $63.75 | $0.00 |
DisclosureSEC source: 0001127602-24-010518 · form4.xml · derivative · entry 3 Wong Robert · CIK 0001777562 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,308 Underlying: Common Stock · 3,308 shares Expires 2034-03-14 F2 · kind: This option shall vest and become exercisable in equal monthly installments over 4 years commencing on April 15, 2024, with the final installment vesting on March 14, 2028. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 23:07 UTC |
Wong RobertVP, Chief Accounting Officer
|
GrantIncentive Stock Option (Right to Buy) · Derivative | 1,403 | $0.00 Strike: $63.75 | $0.00 |
DisclosureSEC source: 0001127602-24-010518 · form4.xml · derivative · entry 2 Wong Robert · CIK 0001777562 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,403 Underlying: Common Stock · 1,403 shares Expires 2034-03-14 F2 · kind: This option shall vest and become exercisable in equal monthly installments over 4 years commencing on April 15, 2024, with the final installment vesting on March 14, 2028. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 23:07 UTC |
Wong RobertVP, Chief Accounting Officer
|
GrantCommon Stock | 4,079 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-010518 · form4.xml · nonDerivative · entry 1 Wong Robert · CIK 0001777562 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,664 F1 · kind: Comprised of restricted stock units that will vest over 3 years, with 40% vesting on the 1-year anniversary of the grant, an additional 40% vesting on the 2-year anniversary of the grant, and the final 20% vesting on the 3-year anniversary of the grant. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 23:02 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
GrantIncentive Stock Option (Right to Buy) · Derivative | 1,224 | $0.00 Strike: $63.75 | $0.00 |
DisclosureSEC source: 0001127602-24-010517 · form4.xml · derivative · entry 3 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,224 Underlying: Common Stock · 1,224 shares Expires 2034-03-14 F2 · kind: This option shall vest and become exercisable in equal monthly installments over 4 years commencing on April 15, 2024, with the final installment vesting on March 14, 2028. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 23:02 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 18,346 | $0.00 Strike: $63.75 | $0.00 |
DisclosureSEC source: 0001127602-24-010517 · form4.xml · derivative · entry 2 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,346 Underlying: Common Stock · 18,346 shares Expires 2034-03-14 F2 · kind: This option shall vest and become exercisable in equal monthly installments over 4 years commencing on April 15, 2024, with the final installment vesting on March 14, 2028. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 23:02 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
GrantCommon Stock | 16,941 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-010517 · form4.xml · nonDerivative · entry 1 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,887 F1 · kind: Award comprised of Restricted Stock Units that will vest over 3-years, with 40% vesting on the 1-year anniversary of the date of grant, an additional 40% vesting on the 2-year anniversary of the date of grant, and the remaining 20% vesting on the 3-year anniversary of the date of grant. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 22:57 UTC |
Malik Fady IbrahamEVP Research & Development
|
GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 23,103 | $0.00 Strike: $63.75 | $0.00 |
DisclosureSEC source: 0001127602-24-010516 · form4.xml · derivative · entry 3 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,103 Underlying: Common Stock · 23,103 shares Expires 2034-03-14 F2 · kind: This option shall vest and become exercisable in equal monthly installments over 4 years commencing on April 15, 2024, with the final installment vesting on March 14, 2034. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 22:57 UTC |
Malik Fady IbrahamEVP Research & Development
|
GrantIncentive Stock Option (Right to Buy) · Derivative | 1,541 | $0.00 Strike: $63.75 | $0.00 |
DisclosureSEC source: 0001127602-24-010516 · form4.xml · derivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,541 Underlying: Common Stock · 1,541 shares Expires 2034-03-13 F2 · kind: This option shall vest and become exercisable in equal monthly installments over 4 years commencing on April 15, 2024, with the final installment vesting on March 14, 2034. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 22:57 UTC |
Malik Fady IbrahamEVP Research & Development
|
GrantCommon Stock | 21,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-010516 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,567 F1 · kind: Award comprised of Restricted Stock Units that will vest over 3-years, with 40% vesting on the 1-year anniversary of the date of grant, an additional 40% vesting on the 2-year anniversary of the date of grant, and the remaining 20% vesting on the 3-year anniversary of the date of grant. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 22:52 UTC |
Blum Robert IDirector · President & CEO
|
GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 69,464 | $0.00 Strike: $63.75 | $0.00 |
DisclosureSEC source: 0001127602-24-010515 · form4.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,464 Underlying: Common Stock · 69,464 shares Expires 2034-03-14 F4 · kind: Award comprised of Non Statutory Stock Options that will vest and become exercisable over 4 years in monthly installments starting April 15, 2024, with the final monthly installment vesting on March 14, 2028. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.